Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK498083Aexternal-prioritypatent/DK498083A/en
Application filed by Univ CaliforniafiledCriticalUniv California
Priority to DK200100932ApriorityCriticalpatent/DK174458B1/en
Publication of DK200100932ApublicationCriticalpatent/DK200100932A/en
Application grantedgrantedCritical
Publication of DK174458B1publicationCriticalpatent/DK174458B1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms
(AREA)
Abstract
The following are claimed: (A) a method for evaluating the possibility of cellular malignancy in a human host, comprising (a) contacting a probe specific for a cellular product (I) with a source (e.g. cells or physiological fluid) from the host suspected of contg. (I), where (I) is mRNA or its expression product, the mRNA being complementary to a DNA sequence of a retrovirus capable of transforming a normal cell to malignancy, and (b) determining the level of binding of the probe to (I) as indicative of the presence of cellular malignancy; and e.g. - (C) 41 antigenic oligopeptides (II), antibodies raised to such oligopeptides, and antigenic oligopeptides contg. up to 50 amino acid residues including one or more of the amino acid sequences of (II). - (Dwg.0/0)
DK200100932A1982-11-042001-06-15Detection and treatment of cancer - using antibodies to oncogenic expression prods.
DK174458B1
(en)
Chromogenic esters of amino acids and peptides, processes for their preparation, use of these agents in methods of analysis and agents for detection of esterolytic and/or proteolytic enzymes.
Nucleic acid coding for the human angiotensine conversion enzyme (ace), and its applications particularly for the in vitro diagnosis of high blood pressure
New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
HUMAN CYCLIN-A COMPOSITIONS, METHOD FOR THE PRODUCTION THEREOF, NUCLEOTIDE SEQUENCE, METHODS AND ACTIVE SUBSTANCES FOR DETERMINING OR DIAGNOSING CELL REPRODUCTION, METHODS AND ACTIVE SUBSTANCES FOR INHIBITING CELL REPRODUCTION